A significant feature of macrophages is dynamic plasticity, expressed by their ability to polarize towards distinct activation states (Lundahl et al., 2017; Sica et al., 2015). Activation with interferon gamma (IFNγ) together with lipopolysaccharides (LPS) yields the bactericidal and pro-inflammatory ‘classically activated’ or M1 macrophages (Ferrante and Leibovich, 2012; Sica et al., 2015), whereas activation with the type 2 and regulatory cytokines, interleukin (IL)–4, IL-13, IL-10 and transforming growth factor (TGF)β, results in ‘alternatively activated’ M2 macrophages, which enhance allergic responses, resolve inflammation and induce tissue remodeling (Bystrom et al., 2008; Mantovani et al., 2004). Another key difference between these activation states are their metabolic profiles: whereas classically activated macrophages switch to near exclusive use of glycolysis to drive their ATP production, alternatively activated macrophages instead upregulate their oxidative phosphorylation (OXPHOS) machinery (Van den Bossche et al., 2016; Van den Bossche et al., 2017).

Macrophages are key host innate immune cells for controlling the causative agent of tuberculosis (TB), Mycobacterium tuberculosis (Cohen et al., 2018). M. tuberculosis has arguably caused the most deaths of any pathogen in human history and continues to be the cause of more than a million deaths annually: in 2020, 10 million people fell ill with active TB and 1.5 million died from the disease (World Health Organization team, 2021). Whilst classifying macrophages into classical and alternative activation states is a simplification – the reality is a broad spectrum of various differentiation states that is continuously regulated by a myriad of signals (Sica et al., 2015) – it is nevertheless considered that for a host to control TB infection, classical macrophage activation is vital (Jouanguy et al., 1999; Philips and Ernst, 2012). Furthermore, a macrophage metabolic shift to glycolysis has been postulated to be a key for effective killing and thus overall control of TB infection (Gleeson et al., 2016; Huang et al., 2018). By contrast, alternatively activated macrophages directly oppose bactericidal responses, which has been demonstrated to lead to enhanced bacterial burden and TB pathology (Moreira-Teixeira et al., 2016; Shi et al., 2019). Due in part to the established ability of classically activated macrophages to kill M. tuberculosis, inducing Th1 immunity has been a key aim for TB vaccine development (Abebe, 2012; Andersen and Kaufmann, 2014; Ottenhoff et al., 2010). Apart from targeting adaptive immune memory, another promising approach has emerged in recent years: bolstering innate immune killing capacity by the induction of innate training (Khader et al., 2019; Moorlag et al., 2020).

Innate training is regarded as a form of immunological memory. It is a phenomenon where a primary challenge, such as a vaccination or an infection, induces epigenetic changes in innate immune cells, which alters their responses following a secondary challenge (Arts et al., 2018; Saeed et al., 2014; van der Meer et al., 2015). Unlike adaptive immune memory, the secondary challenge does not need to be related to the primary challenge. For instance, Bacille Calmette-Guérin (BCG) vaccination has been demonstrated to protect severe combined immunodeficiency (SCID) mice from lethal Candida albicans infection; reducing fungal burden and significantly improving survival (Kleinnijenhuis et al., 2012). This ability of the BCG vaccine to train innate immunity is now believed to be a mechanism by which it induces its protection against M. tuberculosis. Apart from the BCG vaccine, it has been demonstrated that other organisms and compounds can induce innate training, such as β-glucan (van der Meer et al., 2015) which induced protective innate training against virulent M. tuberculosis, as shown by enhanced mouse survival following in vivo infection, and enhanced human monocyte pro-inflammatory cytokine secretion following ex vivo infection (Moorlag et al., 2020).

Conversely, there is a risk that certain immune challenges could lead to innate immune re-programming that hinders protective immune responses. For instance, recent reports have demonstrated how virulent M. tuberculosis (Khan et al., 2020) and mycobacterial phenolic glycans (Lundahl et al., 2020) can program macrophages to attenuate bactericidal responses to subsequent mycobacterial challenge. In the current study, macrophage activation caused by former or concurrent parasitic infections is considered regarding the possibility of innate immune re-programming that hinders protective immune responses against this disease. Geographically, there is extensive overlap between tuberculosis endemic areas and the presence of helminths (Salgame et al., 2013). With regard to macrophage activation and combatting tuberculosis, this is an issue as parasites induce type 2 responses, leading to alternative macrophage activation instead of classical activation and associated bactericidal responses (Chatterjee et al., 2017; Li and Zhou, 2013). Indeed, it was recently demonstrated how products of the helminth Fasciola hepatica can train murine macrophages for enhanced secretion of the anti-inflammatory cytokine IL-10 (Quinn et al., 2019).

Due to the relevance of macrophage plasticity for the control of mycobacterial infection, we primarily focused upon macrophage activation and training in this context. Unexpectedly, our data indicates that macrophage activation with IL-4 and IL-13 induces innate training that enhances pro-inflammatory and bactericidal responses against mycobacteria. Although murine macrophages trained with IL-4 and IL-13 resemble classically activated macrophages, we identify that they do not adopt their typical metabolic profile, instead retaining heightened OXPHOS activity and notably lacking a dependency on glucose and glycolysis. Lastly, we identify IL-10 as a negative regulator of this innate training response, which may have obscured previous identification of this macrophage phenotype.

Although ‘classical’ and ‘alternative’ activation are used to describe the two extremes of macrophage polarization, the reality is that a broad spectrum of activation states exist, affected by a multitude of signals. Macrophages are key immune cells for determining the outcome of TB disease, and growing evidence indicates that the macrophage population during M. tuberculosis infection is highly heterogeneous. Thus, elucidating which subtypes best impede the bacterium is critical for understanding disease control (Khan et al., 2019). Alternative macrophage activation is particularly relevant to TB pathology, both because alveolar macrophages – the initial hosts of M. tuberculosis upon infection – are biased towards alternative activation (Huang et al., 2019), and also considering the influence of concurrent parasitic infection. Given its ultimate relevance in TB pathology, macrophage activation was used as the framework for the work presented herein. The results demonstrate that stimuli of alternative macrophage activation impact innate immune memory, which provides an additional dimension to the noted diversity among macrophage populations.

The current work demonstrates that prior activation with IL-4 and IL-13 enhances anti-mycobacterial responses towards a subsequent challenge, including enhanced inflammatory cytokine secretion (Figure 2A) and BCG killing capacity (Figure 1D). Regarding how this phenomenon is driven, inhibition of DNA methylation prior to activation with IL-4 and IL-13 impeded the enhanced inflammatory cytokine secretion induced by a secondary challenge, suggesting that this effect is mediated, at least in part, via epigenetic modification (Figure 2—figure supplement 3A). However, the role of epigenetic changes – a hallmark for innate training – for the induction of these enhanced responses remains to be addressed in future studies. A role for DNA methylation is in part supported by prior work showing that epigenetic reprogramming is a key component of alternative macrophage activation – crucially de-methylation of H3K27me3 at promoters of key genes such as Arg1, Retnla and Chitl3 is required for their expression (Ishii et al., 2009; Liu et al., 2017). However, whether certain epigenetic changes are sustained, or perhaps altered, between the acute activation stage on Day 0 and the secondary stimulation on Day 6 remains to be investigated. Furthermore, given that epigenetic modification is important for alternative macrophage activation, impeding DNA methylation may have also had a downstream effect upon IL-4 and IL-13 activation, which in turn could have resulted in the reduced inflammatory cytokine secretion to subsequent challenge.

Although further research is required to comprehensively map which mechanism is driving this innate training phenomenon, the current study identifies a macrophage phenotype that is counterintuitively induced by cytokines previously associated with suboptimal mycobacterial containment. Whilst alternatively activated macrophages have been demonstrated to provide an intracellular environment that is favorable for TB growth (Kahnert et al., 2006), resulting in greater bacterial burden (Moreira-Teixeira et al., 2016) in an acute setting, there have been some conflicting data concerning the interplay between parasites and mycobacterial infection. Parasitic infection has been shown to enhance mycobacterial bacterial burden in vivo (Monin et al., 2015; Potian et al., 2011) and enhance human TB pathology (Amelio et al., 2017; Mabbott, 2018), but has in some cases also been shown to enhance protection against mycobacterial infection (Aira et al., 2017; O’Shea et al., 2018). Furthermore, discrepancies have been highlighted specifically regarding macrophage activation. In a model of M. tuberculosis macrophage infection in vitro, prior incubation (48 hr) with antigens from Hymenolepis diminuta, Trichuris muris and Schistosoma mansoni resulted in alternative macrophage activation, but only incubation with the H. diminuta and T. muris antigens resulted in enhanced mycobacterial growth (Aira et al., 2017). Moreover, the increased growth was accompanied by enhanced secretion of IL-10. This however was not surprising, given that IL-10 has been demonstrated to prevent phagolysosome maturation in human macrophages (O’Leary et al., 2011) and promote TB disease progression in mice (Beamer et al., 2008). Herein, an additional mechanism is proposed, where IL-10 reduces IL-4 and IL-13 induced macrophage training and subsequent control of mycobacterial challenge.

BMDM activation with IL-4 and IL-13, with or without the addition of IL-10, resulted in similar activation states: comparable expression of Arg1, Retnla and Chil3 on Day 0 (Figure 6B) and 7 (Figure 6—figure supplement 1C7), reduced expression of CD80 and upregulation of CD206 on Day 0 (Figure 6—figure supplement 1B), as well as reduced secretion of cytokines TNFα, IL-6 and IL-10 following stimulation with Mtb on Day 0 (Figure 6—figure supplement 1AA). Whilst this hyporesponsive profile was maintained in the M(4/13/10), the trained M(4/13) on the other hand demonstrated enhanced pro-inflammatory and bactericidal mechanisms in response to mycobacterial challenge a week after initial activation (Figure 6). This intimated that IL-10 was a negative regulator of innate training induced by IL-4 and IL-13 and indicates that distinct cytokine-mediated modes of alternative macrophage activation differ regarding their innate memory programming. The ability of IL-10 to modulate innate training was herein further demonstrated by investigating innate memory induced by β-glucan (Figure 6G), where the addition of IL-10 during the training stage resulted in attenuated cytokine secretion following secondary LPS stimulation. This discovery has thereby revealed an exciting avenue for future research in this field.

In response to mycobacterial challenge the IL-4 and IL-13 trained cells adopted a phenotype similar to classically activated BMDMs: a skewing towards pro-inflammatory cytokine secretion with concomitant increased expression of Nos2 and NO production (Figure 2), as well as enhanced mycobacterial killing capacity (Figure 1). Classical macrophage activation is intrinsically linked with a glycolytic shift in metabolism; it is thus not surprising that prior work has identified an enhancement of glycolysis as critical for efficient M. tuberculosis killing (Gleeson et al., 2016; Huang et al., 2018), and that impeding glycolysis attenuates the ability of macrophages to control TB infection (Hackett et al., 2020). Moreover, upon M. tuberculosis infection, macrophages appear to undergo a biphasic metabolic profile, where they switch from an initial increase in glycolytic metabolism to an enhancement of the TCA cycle and OXPHOS, a switch which allows mycobacterial survival and disease progression (Shi et al., 2019). As such, it was expected that the trained M(4/13) would shift towards glycolytic metabolism. However, this was not the case, as Mtb stimulation resulted in enhanced OCR and SRC, indicating the use and upregulation of OXPHOS (Figure 3). Furthermore, LC-MS analysis of metabolites indicated increased use of FAO, as well as enhanced creatine, further supporting the continued use of M2-typical metabolism. This was moreover confirmed with the use of the ATP synthase inhibitor oligomycin, where it was demonstrated that inhibition of OXPHOS reduced trained M(4/13) cytokine secretion; by contrast, TNFα upregulation in M(IFNγ/LPS) was unaffected. Furthermore, when trained M(4/13) were incubated in a glucose depleted environment during the week preceding secondary stimulation, the pro-inflammatory shift was enhanced as reflected in increased TNFα and IL-6 secretion combined with reduced IL-10 production (Figure 4B). This was in stark contrast to the effect of glucose depletion on untrained M(-) and trained M(IFNγ/LPS), where the secretion of all measured cytokines was attenuated. This contrast between M(4/13) and M(IFNγ/LPS) cemented their differences regarding metabolic dependency on glucose. It should be noted that prior work has identified differences in macrophage metabolic profiles in response to infection with live M. tuberculosis compared with the killed bacterium or infection with attenuated BCG (Cumming et al., 2018). However, the consensus is that classic macrophage activation, and an accompanying shift to glycolytic metabolism, is paramount for effective mycobacterial killing and propagation of inflammatory responses. It is surprising therefore that these results summarily intimated that trained M(4/13) do not rely on glycolysis to fuel anti-mycobacterial responses.

The addition of a glycolysis inhibitor reduced cytokine secretion, from M(-), M(IFNγ/LPS), as well as M(4/13) following secondary stimulation (Figure 3—figure supplement 2A-B). That inhibition of glycolysis impeded pro-inflammatory cytokine secretion, but glucose depletion did not, indicated that glycolysis in trained M(4/13) was fueling the TCA cycle and downstream OXPHOS, and upon glucose depletion, other pathways, such as glutaminolysis, were compensating for this loss. Glutaminolysis has been shown to be upregulated following macrophage activation with IL-4 and has been demonstrated to compensate for glycolysis inhibition in driving the TCA cycle and OXPHOS (Wang et al., 2018). In the present study, it was moreover observed that the use of a glutaminolysis inhibitor reduced TNFα and IL-6 secretion following secondary stimulation in trained M(4/13) specifically, and not in untrained M(-) or trained M(IFNγ/LPS) (Figure 4A). This work suggests that OXPHOS can be important for pro-inflammatory responses, an observation that is supported by previous work demonstrating that mitochondrial stress is a mechanism of macrophage tolerance (Timblin et al., 2021) and that the ETC is important for nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activity (Billingham et al., 2022). In the latter study, however, LPS induced TNFα secretion was not impeded by inhibition of ETC complexes I and II, demonstrating once more that the metabolic phenotype of the trained M(4/13), explored in the current study, is highly unexpected and warrants further study.

Regarding classical macrophage activation, in the current study concurrent LPS and IFNγ stimulation did not appear to lead to tolerance, as secondary stimulation with Mtb on Day 0 (Figure 2—figure supplement 1D) or Day 6 (Figure 2A) resulted in enhanced TNFα and dampened IL-10 secretion. This is somewhat contrary to prior work demonstrating how LPS induces tolerance in macrophages (Domínguez-Andrés et al., 2019; Timblin et al., 2021). This discrepancy may be due to the relatively low concentration of LPS employed in the present study, and/or the concurrent stimulation with IFNγ. However, although tolerance was not induced, for the classically activated BMDMs and MoDMs there was a reduction in viability over time; as a result there were too few cells to reach the detection limit to measure extracellular flux in the trained M(IFNγ/LPS) BMDM. It could be that the metabolic switch to aerobic glycolysis results in a macrophage phenotype that cannot be sustained over such a long period in culture. Overall, this presumed loss of viability greatly limited the number of experiments where trained M(IL-4/13) could be directly compared with trained M(IFNγ/LPS). Although further investigation of long-term activation states of M(IFNγ/LPS) are warranted, the accumulated results for M(IFNγ/LPS) in the current study demonstrate the distinctive metabolic phenotype driving the inflammatory responses in the trained M(IL-4/13).

The metabolic profile in trained M(4/13), as summarized in Figure 5, is not only distinct from classically activated macrophages, but also from that seen with other training stimuli, such as β-glucan. Innate training is being tested as a means to bolster innate immunity against M. tuberculosis (Khader et al., 2019) and it was recently reported that training with β-glucan was protective against subsequent M tuberculosis infection, as seen by enhanced human monocyte pro-inflammatory cytokine secretion and increased mouse survival in vivo (Moorlag et al., 2020). Similar to classical macrophage activation, β-glucan training results in a glycolytic shift, as demonstrated in human monocytes (Cheng et al., 2014). As such, the phenotype of the trained M(4/13) is distinct from other macrophage phenotypes previously demonstrated to protect against TB, and thus offers an additional avenue for future research regarding strategies for combatting this disease.

The majority of the presented experiments were carried out in a murine in vitro system, using live BCG or irradiated M. tuberculosis H37Rv. Therefore, future work should address the translation of our findings to TB in vivo models, as well as in the context of human TB disease pathology. Regarding metabolic profiles, prior work has identified differences in human macrophage metabolic phenotypes in response to infection with live virulent M. tuberculosis compared with the killed bacterium or infection with BCG; BCG induced greater glycolytic metabolism, whilst infection with virulent M. tuberculosis H37Rv resulted in a quiescent phenotype where both extracellular acidification and oxygen consumption were dampened with increasing MOI (Cumming et al., 2018). Although preliminary work herein has demonstrated that human monocyte derived macrophages trained with IL-4 and IL-13 show a markedly enhanced secretion of TNFα in response to secondary stimulation with either irradiated Mtb (Figure 7) or PAM3CSK4 (Figure 7—figure supplement 1), the metabolic profile driving these responses remains to be investigated, as well as how this macrophage activation state would impact on the outcome of infection with virulent M. tuberculosis.

Van den Bossche et al., 2016 highlighted a key adaptive distinction between classical and alternative macrophage activation: that alternatively activated macrophages can be ‘re-polarized’ due to their metabolic versatility, whereas the mitochondrial dysfunction which occurs during classical macrophage activation prevents such reprogramming. The current study identifies an additional adaptive capacity where activation of macrophages with IL-4 and IL-13 programs BMDMs to better respond to a subsequent mycobacterial challenge, whilst crucially retaining their metabolic diversity. In conclusion, our work presents a new insight into how innate training with IL-4 and IL-13 can enhance macrophage pro-inflammatory responses and mycobacterial killing. This unexpected finding shows how macrophage plasticity belies the usual M1-M2 dichotomy and provides a new framework to explore the impact of comorbidities, such as parasitic infections, on TB disease burden.

All data generated or analysed during this study are included in the manuscript and supporting files. Source data were submitted to Mendeley (https://doi.org/10.17632/ncbph43m85.3).

1. 1. Lundahl MLE
   2. Mitermite M
   3. Ryan D
   4. Case S
   5. Williams N
   6. Yany M
   7. Lynch R
   8. Lagan E
   9. Lebre F
   10. Gorman A
   11. Stojkovic B
   12. Bracken A
   13. Frezza C
   14. Sheedy F
   15. Scanlan E
   16. O'Neill L
   17. Gordon S
   18. Lavelle E

   (2022) Mendeley Data

   Macrophage Innate Training Induced by IL-4 Activation Enhances OXPHOS Driven Anti-Mycobacterial Responses.

   https://doi.org/10.17632/ncbph43m85.3

1. 1. Abebe F

   (2012) Is interferon-gamma the right marker for Bacille calmette-guérin-induced immune protection? the missing link in our understanding of tuberculosis immunology

   Clinical and Experimental Immunology 169:213–219.

   https://doi.org/10.1111/j.1365-2249.2012.04614.x

   • PubMed
   • Google Scholar
2. 1. Aira N
   2. Andersson AM
   3. Singh SK
   4. McKay DM
   5. Blomgran R

   (2017) Species dependent impact of helminth-derived antigens on human macrophages infected with Mycobacterium tuberculosis: direct effect on the innate anti-mycobacterial response

   PLOS Neglected Tropical Diseases 11:e0005390.

   https://doi.org/10.1371/journal.pntd.0005390

   • PubMed
   • Google Scholar
3. 1. Amelio P
   2. Portevin D
   3. Reither K
   4. Mhimbira F
   5. Mpina M
   6. Tumbo A
   7. Nickel B
   8. Marti H
   9. Knopp S
   10. Ding S
   11. Penn-Nicholson A
   12. Darboe F
   13. Ohmiti K
   14. Scriba TJ
   15. Pantaleo G
   16. Daubenberger C
   17. Perreau M

   (2017) Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania

   PLOS Neglected Tropical Diseases 11:e0005817.

   https://doi.org/10.1371/journal.pntd.0005817

   • PubMed
   • Google Scholar
4. 1. Andersen P
   2. Kaufmann SHE

   (2014) Novel vaccination strategies against tuberculosis

   Cold Spring Harbor Perspectives in Medicine 4:a018523.

   https://doi.org/10.1101/cshperspect.a018523

   • PubMed
   • Google Scholar
5. 1. Arts RJW
   2. Moorlag S
   3. Novakovic B
   4. Li Y
   5. Wang SY
   6. Oosting M
   7. Kumar V
   8. Xavier RJ
   9. Wijmenga C
   10. Joosten LAB
   11. Reusken C
   12. Benn CS
   13. Aaby P
   14. Koopmans MP
   15. Stunnenberg HG
   16. van Crevel R
   17. Netea MG

   (2018) Bcg vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity

   Cell Host & Microbe 23:89–100.

   https://doi.org/10.1016/j.chom.2017.12.010

   • PubMed
   • Google Scholar
6. 1. Beamer GL
   2. Flaherty DK
   3. Assogba BD
   4. Stromberg P
   5. Gonzalez-Juarrero M
   6. de Waal Malefyt R
   7. Vesosky B
   8. Turner J

   (2008) Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice

   Journal of Immunology 181:5545–5550.

   https://doi.org/10.4049/jimmunol.181.8.5545

   • PubMed
   • Google Scholar
7. 1. Billingham LK
   2. Stoolman JS
   3. Vasan K
   4. Rodriguez AE
   5. Poor TA
   6. Szibor M
   7. Jacobs HT
   8. Reczek CR
   9. Rashidi A
   10. Zhang P
   11. Miska J
   12. Chandel NS

   (2022) Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation

   Nature Immunology 23:692–704.

   https://doi.org/10.1038/s41590-022-01185-3

   • PubMed
   • Google Scholar
8. 1. Bourigault ML
   2. Segueni N
   3. Rose S
   4. Court N
   5. Vacher R
   6. Vasseur V
   7. Erard F
   8. Le Bert M
   9. Garcia I
   10. Iwakura Y
   11. Jacobs M
   12. Ryffel B
   13. Quesniaux VFJ

   (2013) Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG

   Immunity, Inflammation and Disease 1:47–62.

   https://doi.org/10.1002/iid3.9

   • PubMed
   • Google Scholar
9. 1. Brown GD
   2. Crocker PR

   (2016) Lectin receptors expressed on myeloid cells

   Microbiology Spectrum 4:0036-2016.

   https://doi.org/10.1128/microbiolspec.MCHD-0036-2016

   • PubMed
   • Google Scholar
10. 1. Bystrom J
    2. Evans I
    3. Newson J
    4. Stables M
    5. Toor I
    6. van Rooijen N
    7. Crawford M
    8. Colville-Nash P
    9. Farrow S
    10. Gilroy DW

    (2008) Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP

    Blood 112:4117–4127.

    https://doi.org/10.1182/blood-2007-12-129767

    • PubMed
    • Google Scholar
11. 1. Chatterjee S
    2. Talaat KR
    3. van Seventer EE
    4. Feng CG
    5. Scott AL
    6. Jedlicka A
    7. Dziedzic A
    8. Nutman TB
    9. Rottenberg ME

    (2017) Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages

    PLOS ONE 12:e0179701.

    https://doi.org/10.1371/journal.pone.0179701

    • PubMed
    • Google Scholar
12. 1. Cheng SC
    2. Quintin J
    3. Cramer RA
    4. Shepardson KM
    5. Saeed S
    6. Kumar V
    7. Giamarellos-Bourboulis EJ
    8. Martens JHA
    9. Rao NA
    10. Aghajanirefah A
    11. Manjeri GR
    12. Li Y
    13. Ifrim DC
    14. Arts RJW
    15. van der Veer B
    16. Deen PMT
    17. Logie C
    18. O’Neill LA
    19. Willems P
    20. van de Veerdonk FL
    21. van der Meer JWM
    22. Ng A
    23. Joosten LAB
    24. Wijmenga C
    25. Stunnenberg HG
    26. Xavier RJ
    27. Netea MG

    (2014) MTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity

    Science 345:1250684.

    https://doi.org/10.1126/science.1250684

    • PubMed
    • Google Scholar
13. 1. Cohen SB
    2. Gern BH
    3. Delahaye JL
    4. Adams KN
    5. Plumlee CR
    6. Winkler JK
    7. Sherman DR
    8. Gerner MY
    9. Urdahl KB

    (2018) Alveolar macrophages provide an early Mycobacterium tuberculosis niche and initiate dissemination

    Cell Host & Microbe 24:439–446.

    https://doi.org/10.1016/j.chom.2018.08.001

    • PubMed
    • Google Scholar
14. 1. Cumming BM
    2. Addicott KW
    3. Adamson JH
    4. Steyn AJC

    (2018) Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages

    eLife 7:e39169.

    https://doi.org/10.7554/eLife.39169

    • PubMed
    • Google Scholar
15. 1. Domínguez-Andrés J
    2. Novakovic B
    3. Li Y
    4. Scicluna BP
    5. Gresnigt MS
    6. Arts RJW
    7. Oosting M
    8. Moorlag S
    9. Groh LA
    10. Zwaag J
    11. Koch RM
    12. ter Horst R
    13. Joosten LAB
    14. Wijmenga C
    15. Michelucci A
    16. van der Poll T
    17. Kox M
    18. Pickkers P
    19. Kumar V
    20. Stunnenberg H
    21. Netea MG

    (2019) The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity

    Cell Metabolism 29:211–220.

    https://doi.org/10.1016/j.cmet.2018.09.003

    • PubMed
    • Google Scholar
16. 1. Ferrante CJ
    2. Leibovich SJ

    (2012) Regulation of macrophage polarization and wound healing

    Advances in Wound Care 1:10–16.

    https://doi.org/10.1089/wound.2011.0307

    • PubMed
    • Google Scholar
17. 1. Flynn JL
    2. Chan J
    3. Triebold KJ
    4. Dalton DK
    5. Stewart TA
    6. Bloom BR

    (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

    The Journal of Experimental Medicine 178:2249–2254.

    https://doi.org/10.1084/jem.178.6.2249

    • PubMed
    • Google Scholar
18. 1. Gabrilovich DI
    2. Ostrand-Rosenberg S
    3. Bronte V

    (2012) Coordinated regulation of myeloid cells by tumours

    Nature Reviews. Immunology 12:253–268.

    https://doi.org/10.1038/nri3175

    • PubMed
    • Google Scholar
19. 1. Gause WC
    2. Wynn TA
    3. Allen JE

    (2013) Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths

    Nature Reviews. Immunology 13:607–614.

    https://doi.org/10.1038/nri3476

    • PubMed
    • Google Scholar
20. 1. Gleeson LE
    2. Sheedy FJ
    3. Palsson-McDermott EM
    4. Triglia D
    5. O’Leary SM
    6. O’Sullivan MP
    7. O’Neill LAJ
    8. Keane J

    (2016) Cutting edge: Mycobacterium tuberculosis induces aerobic glycolysis in human alveolar macrophages that is required for control of intracellular bacillary replication

    Journal of Immunology 196:2444–2449.

    https://doi.org/10.4049/jimmunol.1501612

    • PubMed
    • Google Scholar
21. 1. Gordon S
    2. Martinez FO

    (2010) Alternative activation of macrophages: mechanism and functions

    Immunity 32:593–604.

    https://doi.org/10.1016/j.immuni.2010.05.007

    • PubMed
    • Google Scholar
22. 1. Hackett EE
    2. Charles-Messance H
    3. O’Leary SM
    4. Gleeson LE
    5. Muñoz-Wolf N
    6. Case S
    7. Wedderburn A
    8. Johnston DGW
    9. Williams MA
    10. Smyth A
    11. Ouimet M
    12. Moore KJ
    13. Lavelle EC
    14. Corr SC
    15. Gordon SV
    16. Keane J
    17. Sheedy FJ

    (2020) Mycobacterium tuberculosis limits host glycolysis and IL-1β by restriction of PFK-M via microRNA-21

    Cell Reports 30:124–136.

    https://doi.org/10.1016/j.celrep.2019.12.015

    • PubMed
    • Google Scholar
23. 1. Huang L
    2. Nazarova EV
    3. Tan S
    4. Liu Y
    5. Russell DG

    (2018) Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny

    The Journal of Experimental Medicine 215:1135–1152.

    https://doi.org/10.1084/jem.20172020

    • PubMed
    • Google Scholar
24. 1. Huang L
    2. Nazarova EV
    3. Russell DG

    (2019) Mycobacterium tuberculosis: bacterial fitness within the host macrophage bacteria and intracellularity

    American Society of Microbiology 7:127–138.

    https://doi.org/10.1128/microbiolspec.BAI-0001-2019

    • Google Scholar
25. 1. Ishii M
    2. Wen H
    3. Corsa CAS
    4. Liu T
    5. Coelho AL
    6. Allen RM
    7. Carson WF
    8. Cavassani KA
    9. Li X
    10. Lukacs NW
    11. Hogaboam CM
    12. Dou Y
    13. Kunkel SL

    (2009) Epigenetic regulation of the alternatively activated macrophage phenotype

    Blood 114:3244–3254.

    https://doi.org/10.1182/blood-2009-04-217620

    • PubMed
    • Google Scholar
26. 1. Jouanguy E
    2. Lamhamedi-Cherradi S
    3. Lammas D
    4. Dorman SE
    5. Fondanèche MC
    6. Dupuis S
    7. Döffinger R
    8. Altare F
    9. Girdlestone J
    10. Emile JF
    11. Ducoulombier H
    12. Edgar D
    13. Clarke J
    14. Oxelius VA
    15. Brai M
    16. Novelli V
    17. Heyne K
    18. Fischer A
    19. Holland SM
    20. Kumararatne DS
    21. Schreiber RD
    22. Casanova JL

    (1999) A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

    Nature Genetics 21:370–378.

    https://doi.org/10.1038/7701

    • PubMed
    • Google Scholar
27. 1. Kahnert A
    2. Seiler P
    3. Stein M
    4. Bandermann S
    5. Hahnke K
    6. Mollenkopf H
    7. Kaufmann SHE

    (2006) Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis

    European Journal of Immunology 36:631–647.

    https://doi.org/10.1002/eji.200535496

    • PubMed
    • Google Scholar
28. 1. Keane J
    2. Gershon S
    3. Wise RP
    4. Mirabile-Levens E
    5. Kasznica J
    6. Schwieterman WD
    7. Siegel JN
    8. Braun MM

    (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

    The New England Journal of Medicine 345:1098–1104.

    https://doi.org/10.1056/NEJMoa011110

    • PubMed
    • Google Scholar
29. 1. Khader SA
    2. Divangahi M
    3. Hanekom W
    4. Hill PC
    5. Maeurer M
    6. Makar KW
    7. Mayer-Barber KD
    8. Mhlanga MM
    9. Nemes E
    10. Schlesinger LS
    11. van Crevel R
    12. Vankayalapati R
    13. Xavier RJ
    14. Netea MG
    15. Bill and Melinda Gates Foundation Collaboration for TB Vaccine Discovery Innate Immunity Working Group18

    (2019) Targeting innate immunity for tuberculosis vaccination

    The Journal of Clinical Investigation 129:3482–3491.

    https://doi.org/10.1172/JCI128877

    • PubMed
    • Google Scholar
30. 1. Khan A
    2. Singh VK
    3. Hunter RL
    4. Jagannath C

    (2019) Macrophage heterogeneity and plasticity in tuberculosis

    Journal of Leukocyte Biology 106:275–282.

    https://doi.org/10.1002/JLB.MR0318-095RR

    • PubMed
    • Google Scholar
31. 1. Khan N
    2. Downey J
    3. Sanz J
    4. Kaufmann E
    5. Blankenhaus B
    6. Pacis A
    7. Pernet E
    8. Ahmed E
    9. Cardoso S
    10. Nijnik A
    11. Mazer B
    12. Sassetti C
    13. Behr MA
    14. Soares MP
    15. Barreiro LB
    16. Divangahi M

    (2020) M. tuberculosis reprograms hematopoietic stem cells to limit myelopoiesis and impair trained immunity

    Cell 183:752–770.

    https://doi.org/10.1016/j.cell.2020.09.062

    • PubMed
    • Google Scholar
32. 1. Kleinnijenhuis J
    2. Quintin J
    3. Preijers F
    4. Joosten LAB
    5. Ifrim DC
    6. Saeed S
    7. Jacobs C
    8. van Loenhout J
    9. de Jong D
    10. Stunnenberg HG
    11. Xavier RJ
    12. van der Meer JWM
    13. van Crevel R
    14. Netea MG

    (2012) Bacille Calmette-Guerin induces Nod2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

    PNAS 109:17537–17542.

    https://doi.org/10.1073/pnas.1202870109

    • PubMed
    • Google Scholar
33. 1. Lebre F
    2. Hanlon D
    3. Boland JB
    4. Coleman J
    5. Lavelle EC

    (2018) Exfoliation in endotoxin‐free albumin generates pristine graphene with reduced inflammatory properties

    Advanced Biosystems 2:1800102.

    https://doi.org/10.1002/adbi.201800102

    • Google Scholar
34. 1. Li XX
    2. Zhou XN

    (2013) Co-Infection of tuberculosis and parasitic diseases in humans: a systematic review

    Parasites & Vectors 6:79.

    https://doi.org/10.1186/1756-3305-6-79

    • PubMed
    • Google Scholar
35. 1. Li L
    2. Ng DSW
    3. Mah WC
    4. Almeida FF
    5. Rahmat SA
    6. Rao VK
    7. Leow SC
    8. Laudisi F
    9. Peh MT
    10. Goh AM
    11. Lim JSY
    12. Wright GD
    13. Mortellaro A
    14. Taneja R
    15. Ginhoux F
    16. Lee CG
    17. Moore PK
    18. Lane DP

    (2015) A unique role for p53 in the regulation of M2 macrophage polarization

    Cell Death and Differentiation 22:1081–1093.

    https://doi.org/10.1038/cdd.2014.212

    • PubMed
    • Google Scholar
36. 1. Liu L
    2. Lu Y
    3. Martinez J
    4. Bi Y
    5. Lian G
    6. Wang T
    7. Milasta S
    8. Wang J
    9. Yang M
    10. Liu G
    11. Green DR
    12. Wang R

    (2016) Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1α-dependent

    PNAS 113:1564–1569.

    https://doi.org/10.1073/pnas.1518000113

    • PubMed
    • Google Scholar
37. 1. Liu PS
    2. Wang H
    3. Li X
    4. Chao T
    5. Teav T
    6. Christen S
    7. Di Conza G
    8. Cheng WC
    9. Chou CH
    10. Vavakova M
    11. Muret C
    12. Debackere K
    13. Mazzone M
    14. Huang HD
    15. Fendt SM
    16. Ivanisevic J
    17. Ho PC

    (2017) Α-Ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming

    Nature Immunology 18:985–994.

    https://doi.org/10.1038/ni.3796

    • PubMed
    • Google Scholar
38. 1. Luiz JPM
    2. Toller-Kawahisa JE
    3. Viacava PR
    4. Nascimento DC
    5. Pereira PT
    6. Saraiva AL
    7. Prado DS
    8. LeBert M
    9. Giurisato E
    10. Tournier C
    11. Cunha TM
    12. Cunha FQ
    13. Quesniaux V
    14. Ryffel B
    15. Alves-Filho JC

    (2020) Mek5/Erk5 signaling mediates IL-4-induced M2 macrophage differentiation through regulation of c-myc expression

    Journal of Leukocyte Biology 108:1215–1223.

    https://doi.org/10.1002/JLB.1MA0520-016R

    • PubMed
    • Google Scholar
39. 1. Lundahl MLE
    2. Scanlan EM
    3. Lavelle EC

    (2017) Therapeutic potential of carbohydrates as regulators of macrophage activation

    Biochemical Pharmacology 146:23–41.

    https://doi.org/10.1016/j.bcp.2017.09.003

    • PubMed
    • Google Scholar
40. 1. Lundahl M
    2. Lynch DM
    3. Barnes D
    4. McSweeney L
    5. Gorman A
    6. Lebre F
    7. Gordon SV
    8. Lavelle EC
    9. Scanlan EM

    (2020) Mycobacterial para-hydroxybenzoic acid-derivatives (phbads) and related structures induce macrophage innate memory

    ACS Chemical Biology 15:2415–2421.

    https://doi.org/10.1021/acschembio.0c00378

    • PubMed
    • Google Scholar
41. 1. Mabbott NA

    (2018) The influence of parasite infections on host immunity to co-infection with other pathogens

    Frontiers in Immunology 9:2579.

    https://doi.org/10.3389/fimmu.2018.02579

    • PubMed
    • Google Scholar
42. 1. Mantovani A
    2. Sica A
    3. Sozzani S
    4. Allavena P
    5. Vecchi A
    6. Locati M

    (2004) The chemokine system in diverse forms of macrophage activation and polarization

    Trends in Immunology 25:677–686.

    https://doi.org/10.1016/j.it.2004.09.015

    • PubMed
    • Google Scholar
43. 1. Monin L
    2. Griffiths KL
    3. Lam WY
    4. Gopal R
    5. Kang DD
    6. Ahmed M
    7. Rajamanickam A
    8. Cruz-Lagunas A
    9. Zúñiga J
    10. Babu S
    11. Kolls JK
    12. Mitreva M
    13. Rosa BA
    14. Ramos-Payan R
    15. Morrison TE
    16. Murray PJ
    17. Rangel-Moreno J
    18. Pearce EJ
    19. Khader SA

    (2015) Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis

    The Journal of Clinical Investigation 125:4699–4713.

    https://doi.org/10.1172/JCI77378

    • PubMed
    • Google Scholar
44. 1. Moorlag S
    2. Khan N
    3. Novakovic B
    4. Kaufmann E
    5. Jansen T
    6. van Crevel R
    7. Divangahi M
    8. Netea MG

    (2020) Β-Glucan induces protective trained immunity against Mycobacterium tuberculosis infection: a key role for IL-1

    Cell Reports 31:107634.

    https://doi.org/10.1016/j.celrep.2020.107634

    • PubMed
    • Google Scholar
45. 1. Moreira-Teixeira L
    2. Sousa J
    3. McNab FW
    4. Torrado E
    5. Cardoso F
    6. Machado H
    7. Castro F
    8. Cardoso V
    9. Gaifem J
    10. Wu X
    11. Appelberg R
    12. Castro AG
    13. O’Garra A
    14. Saraiva M

    (2016) Type I IFN inhibits alternative macrophage activation during Mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-γ signaling

    Journal of Immunology 197:4714–4726.

    https://doi.org/10.4049/jimmunol.1600584

    • PubMed
    • Google Scholar
46. 1. Murray PJ
    2. Wynn TA

    (2011) Protective and pathogenic functions of macrophage subsets

    Nature Reviews. Immunology 11:723–737.

    https://doi.org/10.1038/nri3073

    • PubMed
    • Google Scholar
47. 1. O’Leary S
    2. O’Sullivan MP
    3. Keane J

    (2011) Il-10 blocks phagosome maturation in Mycobacterium tuberculosis– infected human macrophages

    American Journal of Respiratory Cell and Molecular Biology 45:172–180.

    https://doi.org/10.1165/rcmb.2010-0319OC

    • PubMed
    • Google Scholar
48. 1. O’Neill LAJ
    2. Kishton RJ
    3. Rathmell J

    (2016) A guide to immunometabolism for immunologists

    Nature Reviews Immunology 16:553–565.

    https://doi.org/10.1038/nri.2016.70

    • PubMed
    • Google Scholar
49. 1. O’Shea MK
    2. Fletcher TE
    3. Muller J
    4. Tanner R
    5. Matsumiya M
    6. Bailey JW
    7. Jones J
    8. Smith SG
    9. Koh G
    10. Horsnell WG
    11. Beeching NJ
    12. Dunbar J
    13. Wilson D
    14. Cunningham AF
    15. McShane H

    (2018) Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection

    Frontiers in Immunology 9:2893.

    https://doi.org/10.3389/fimmu.2018.02893

    • PubMed
    • Google Scholar
50. 1. Ottenhoff THM
    2. Doherty TM
    3. van Dissel JT
    4. Bang P
    5. Lingnau K
    6. Kromann I
    7. Andersen P

    (2010) First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis -specific th1-cell like responses

    Human Vaccines 6:1007–1015.

    https://doi.org/10.4161/hv.6.12.13143

    • PubMed
    • Google Scholar
51. 1. Palsson-McDermott EM
    2. Curtis AM
    3. Goel G
    4. Lauterbach MAR
    5. Sheedy FJ
    6. Gleeson LE
    7. van den Bosch MWM
    8. Quinn SR
    9. Domingo-Fernandez R
    10. Johnston DGW
    11. Jiang JK
    12. Jiang JK
    13. Israelsen WJ
    14. Keane J
    15. Thomas C
    16. Clish C
    17. Vander Heiden M
    18. Vanden Heiden M
    19. Xavier RJ
    20. O’Neill LAJ

    (2015) Pyruvate kinase M2 regulates HIF-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages

    Cell Metabolism 21:65–80.

    https://doi.org/10.1016/j.cmet.2014.12.005

    • PubMed
    • Google Scholar
52. 1. Pasula R
    2. Martin WJ
    3. Kesavalu BR
    4. Abdalla MY
    5. Britigan BE

    (2017) Passive transfer of interferon-γ over-expressing macrophages enhances resistance of SCID mice to Mycobacterium tuberculosis infection

    Cytokine 95:70–79.

    https://doi.org/10.1016/j.cyto.2017.02.009

    • PubMed
    • Google Scholar
53. 1. Philips JA
    2. Ernst JD

    (2012) Tuberculosis pathogenesis and immunity

    Annual Review of Pathology 7:353–384.

    https://doi.org/10.1146/annurev-pathol-011811-132458

    • PubMed
    • Google Scholar
54. 1. Potian JA
    2. Rafi W
    3. Bhatt K
    4. McBride A
    5. Gause WC
    6. Salgame P

    (2011) Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway

    The Journal of Experimental Medicine 208:1863–1874.

    https://doi.org/10.1084/jem.20091473

    • PubMed
    • Google Scholar
55. 1. Quinn SM
    2. Cunningham K
    3. Raverdeau M
    4. Walsh RJ
    5. Curham L
    6. Malara A
    7. Mills KHG

    (2019) Anti-Inflammatory trained immunity mediated by helminth products attenuates the induction of T cell-mediated autoimmune disease

    Frontiers in Immunology 10:1109.

    https://doi.org/10.3389/fimmu.2019.01109

    • PubMed
    • Google Scholar
56. 1. Quintin J
    2. Saeed S
    3. Martens JHA
    4. Giamarellos-Bourboulis EJ
    5. Ifrim DC
    6. Logie C
    7. Jacobs L
    8. Jansen T
    9. Kullberg BJ
    10. Wijmenga C
    11. Joosten LAB
    12. Xavier RJ
    13. van der Meer JWM
    14. Stunnenberg HG
    15. Netea MG

    (2012) Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes

    Cell Host & Microbe 12:223–232.

    https://doi.org/10.1016/j.chom.2012.06.006

    • PubMed
    • Google Scholar
57. 1. Roy S
    2. Mukhopadhyay D
    3. Mukherjee S
    4. Moulik S
    5. Chatterji S
    6. Brahme N
    7. Pramanik N
    8. Goswami RP
    9. Saha B
    10. Chatterjee M

    (2018) An IL-10 dominant polarization of monocytes is a feature of Indian visceral leishmaniasis

    Parasite Immunology 40:e12535.

    https://doi.org/10.1111/pim.12535

    • PubMed
    • Google Scholar
58. 1. Saeed S
    2. Quintin J
    3. Kerstens HHD
    4. Rao NA
    5. Aghajanirefah A
    6. Matarese F
    7. Cheng SC
    8. Ratter J
    9. Berentsen K
    10. van der Ent MA
    11. Sharifi N
    12. Janssen-Megens EM
    13. Ter Huurne M
    14. Mandoli A
    15. van Schaik T
    16. Ng A
    17. Burden F
    18. Downes K
    19. Frontini M
    20. Kumar V
    21. Giamarellos-Bourboulis EJ
    22. Ouwehand WH
    23. van der Meer JWM
    24. Joosten LAB
    25. Wijmenga C
    26. Martens JHA
    27. Xavier RJ
    28. Logie C
    29. Netea MG
    30. Stunnenberg HG

    (2014) Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity

    Science 345:1251086.

    https://doi.org/10.1126/science.1251086

    • PubMed
    • Google Scholar
59. 1. Salgame P
    2. Yap GS
    3. Gause WC

    (2013) Effect of helminth-induced immunity on infections with microbial pathogens

    Nature Immunology 14:1118–1126.

    https://doi.org/10.1038/ni.2736

    • PubMed
    • Google Scholar
60. 1. Seth P
    2. Csizmadia E
    3. Hedblom A
    4. Vuerich M
    5. Xie H
    6. Li M
    7. Longhi MS
    8. Wegiel B

    (2017) Deletion of lactate dehydrogenase-A in myeloid cells triggers antitumor immunity

    Cancer Research 77:3632–3643.

    https://doi.org/10.1158/0008-5472.CAN-16-2938

    • PubMed
    • Google Scholar
61. 1. Shi L
    2. Jiang Q
    3. Bushkin Y
    4. Subbian S
    5. Tyagi S

    (2019) Biphasic dynamics of macrophage immunometabolism during Mycobacterium tuberculosis infection

    MBio 10:e02550-18.

    https://doi.org/10.1128/mBio.02550-18

    • PubMed
    • Google Scholar
62. 1. Sica A
    2. Erreni M
    3. Allavena P
    4. Porta C

    (2015) Macrophage polarization in pathology

    Cellular and Molecular Life Sciences 72:4111–4126.

    https://doi.org/10.1007/s00018-015-1995-y

    • PubMed
    • Google Scholar
63. 1. Timblin GA
    2. Tharp KM
    3. Ford B
    4. Winchester JM
    5. Wang J
    6. Zhu S
    7. Khan RI
    8. Louie SK
    9. Iavarone AT
    10. Ten Hoeve J
    11. Nomura DK
    12. Stahl A
    13. Saijo K

    (2021) Mitohormesis reprogrammes macrophage metabolism to enforce tolerance

    Nature Metabolism 3:618–635.

    https://doi.org/10.1038/s42255-021-00392-w

    • PubMed
    • Google Scholar
64. 1. Van den Bossche J
    2. Baardman J
    3. Otto NA
    4. van der Velden S
    5. Neele AE
    6. van den Berg SM
    7. Luque-Martin R
    8. Chen HJ
    9. Boshuizen MCS
    10. Ahmed M
    11. Hoeksema MA
    12. de Vos AF
    13. de Winther MPJ

    (2016) Mitochondrial dysfunction prevents repolarization of inflammatory macrophages

    Cell Reports 17:684–696.

    https://doi.org/10.1016/j.celrep.2016.09.008

    • PubMed
    • Google Scholar
65. 1. Van den Bossche J
    2. O’Neill LA
    3. Menon D

    (2017) Macrophage immunometabolism: where are we (going)?

    Trends in Immunology 38:395–406.

    https://doi.org/10.1016/j.it.2017.03.001

    • PubMed
    • Google Scholar
66. 1. van der Meer JWM
    2. Joosten LAB
    3. Riksen N
    4. Netea MG

    (2015) Trained immunity: a smart way to enhance innate immune defence

    Molecular Immunology 68:40–44.

    https://doi.org/10.1016/j.molimm.2015.06.019

    • PubMed
    • Google Scholar
67. 1. Viola A
    2. Munari F
    3. Sánchez-Rodríguez R
    4. Scolaro T
    5. Castegna A

    (2019) The metabolic signature of macrophage responses

    Frontiers in Immunology 10:1462.

    https://doi.org/10.3389/fimmu.2019.01462

    • PubMed
    • Google Scholar
68. 1. Wang F
    2. Zhang S
    3. Vuckovic I
    4. Jeon R
    5. Lerman A
    6. Folmes CD
    7. Dzeja PP
    8. Herrmann J

    (2018) Glycolytic stimulation is not a requirement for M2 macrophage differentiation

    Cell Metabolism 28:463–475.

    https://doi.org/10.1016/j.cmet.2018.08.012

    • PubMed
    • Google Scholar
69. Report

    1. World Health Organization team

    (2021) Global Tuberculosis Report 2021

    WHO.

    http://apps.who.int/bookorders

    • Google Scholar

Author details

1. Mimmi LE Lundahl

   1. School of Biochemistry and Immunology, Adjuvant Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
   2. School of Chemistry, Scanlan Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

   Contribution

   Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing

   For correspondence

   lundahlm@tcd.ie

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-3924-4072

2. Morgane Mitermite

   School of Veterinary Medicine, UCD Veterinary Sciences Centre, University College Dublin, Dublin, Ireland

   Contribution

   Formal analysis, Investigation, Methodology, Writing – review and editing

   Contributed equally with

   Dylan Gerard Ryan

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-9169-2134

3. Dylan Gerard Ryan

   1. School of Biochemistry and Immunology, Inflammation Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
   2. Hutchison/MRC Research centre, MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom

   Contribution

   Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing

   Contributed equally with

   Morgane Mitermite

   Competing interests

   No competing interests declared

4. Sarah Case

   School of Biochemistry and Immunology, Macrophage Homeostasis Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

   Contribution

   Methodology

   Competing interests

   No competing interests declared

5. Niamh C Williams

   School of Biochemistry and Immunology, Inflammation Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

   Contribution

   Formal analysis, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

6. Ming Yang

   Hutchison/MRC Research centre, MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom

   Contribution

   Formal analysis, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

7. Roisin I Lynch

   School of Biochemistry and Immunology, Adjuvant Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

   Contribution

   Methodology

   Competing interests

   No competing interests declared

8. Eimear Lagan

   School of Genetics and Microbiology, Department of Genetics, Trinity College Dublin, Dublin, Ireland

   Contribution

   Methodology

   Competing interests

   No competing interests declared

9. Filipa M Lebre

   School of Biochemistry and Immunology, Adjuvant Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

   Contribution

   Formal analysis, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

10. Aoife L Gorman

    School of Biochemistry and Immunology, Adjuvant Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

    Contribution

    Resources, Formal analysis, Investigation, Methodology, Writing – review and editing

    Competing interests

    No competing interests declared

11. Bojan Stojkovic

    School of Veterinary Medicine, UCD Veterinary Sciences Centre, University College Dublin, Dublin, Ireland

    Contribution

    Formal analysis, Investigation, Methodology, Writing – review and editing

    Competing interests

    No competing interests declared

12. Adrian P Bracken

    School of Genetics and Microbiology, Department of Genetics, Trinity College Dublin, Dublin, Ireland

    Contribution

    Investigation

    Competing interests

    No competing interests declared

13. Christian Frezza

    Hutchison/MRC Research centre, MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom

    Contribution

    Data curation, Investigation, Methodology, Writing – review and editing

    Competing interests

    No competing interests declared

14. Frederick J Sheedy

    School of Biochemistry and Immunology, Macrophage Homeostasis Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

    Contribution

    Investigation

    Competing interests

    No competing interests declared

15. Eoin M Scanlan

    School of Chemistry, Scanlan Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

    Contribution

    Formal analysis, Supervision, Project administration, Writing – review and editing

    Competing interests

    No competing interests declared

16. Luke AJ O'Neill

    School of Biochemistry and Immunology, Inflammation Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

    Contribution

    Formal analysis, Investigation, Writing – review and editing

    Competing interests

    No competing interests declared

17. Stephen V Gordon

    School of Veterinary Medicine, UCD Veterinary Sciences Centre, University College Dublin, Dublin, Ireland

    Contribution

    Conceptualization, Resources, Formal analysis, Investigation, Methodology, Writing – review and editing

    Competing interests

    No competing interests declared

18. Ed C Lavelle

    School of Biochemistry and Immunology, Adjuvant Research Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

    Contribution

    Conceptualization, Supervision, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing

    For correspondence

    lavellee@tcd.ie

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-3167-1080

• 4,756

  views

• 774

  downloads

• 36

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.